Scribe Biosciences

About:

Flexible tools for single cell analysis

Website: https://www.scribebiosciences.com/

Top Investors: National Science Foundation, Casdin Capital, Formic Ventures, Harmonix Fund, BioTools Innovator

Description:

Our fundamental technology, Printed Droplet Microfluidics (PDM), is a flexible and reconfigurable fluid handling system to perform picoliter-scale manipulations. By leveraging fluorescence-activated microfluidic droplet sorting and a specialized substrate, PDM enables the flexible and deterministic handling of single cells and fluid aliquots at extremely high throughputs. ​

Total Funding Amount:

$3.13M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

San Francisco, California, United States

Founded Date:

2017-09-01

Contact Email:

info(AT)scribebiosciences.com

Founders:

Adam Abate, Maithreyan Srinivasan, Russell Cole, Zev Gartner

Number of Employees:

11-50

Last Funding Date:

2023-06-06

IPO Status:

Private

Industries:

© 2025 bioDAO.ai